Doximity [DOCS] vs HealthEquity [HQY] Detailed Stock Comparison
Doximity
NYSE
Loading...
HealthEquity
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Doximity wins in 10 metrics, HealthEquity wins in 9 metrics, with 0 ties. Doximity appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Doximity | HealthEquity | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 63.66 | 55.99 | HealthEquity |
| Price-to-Book Ratio | 13.73 | 3.65 | HealthEquity |
| Debt-to-Equity Ratio | 1.16 | 49.15 | Doximity |
| PEG Ratio | 2.33 | 0.82 | HealthEquity |
| EV/EBITDA | 54.29 | 20.70 | HealthEquity |
| Profit Margin (TTM) | 39.88% | 11.49% | Doximity |
| Operating Margin (TTM) | 37.48% | 27.89% | Doximity |
| EBITDA Margin (TTM) | 37.48% | 27.89% | Doximity |
| Return on Equity | 24.25% | 6.78% | Doximity |
| Return on Assets (TTM) | 13.13% | 4.94% | Doximity |
| Free Cash Flow (TTM) | $266.74M | $-165.60M | Doximity |
| 1-Year Return | 66.89% | 7.93% | Doximity |
| Price-to-Sales Ratio (TTM) | 23.63 | 6.27 | HealthEquity |
| Enterprise Value | $13.24B | $8.92B | Doximity |
| EV/Revenue Ratio | 22.46 | 7.03 | HealthEquity |
| Gross Profit Margin (TTM) | 89.18% | 71.38% | Doximity |
| Revenue per Share (TTM) | $3 | $15 | HealthEquity |
| Earnings per Share (Diluted) | $1.18 | $1.62 | HealthEquity |
| Beta (Stock Volatility) | 1.37 | 0.50 | HealthEquity |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Doximity vs HealthEquity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Doximity | 1.91% | -3.21% | 7.45% | 21.38% | 24.23% | 34.41% |
| HealthEquity | -1.14% | -6.74% | 0.93% | -11.45% | 1.06% | -7.36% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Doximity | 66.89% | 146.55% | 30.67% | 30.67% | 30.67% | 30.67% |
| HealthEquity | 7.93% | 33.21% | 62.46% | 196.56% | 429.09% | 429.09% |
News Based Sentiment: Doximity vs HealthEquity
Doximity
News based Sentiment: MIXED
October brought a mix of positive financial projections and concerning signals for Doximity. While the company is expected to continue growing revenue and earnings, a downgrade from Goldman Sachs, significant insider selling, and potential regulatory risks create uncertainty. This combination of factors makes October a significant month for investors to reassess their positions.
HealthEquity
News based Sentiment: POSITIVE
HealthEquity experienced a remarkably positive month, driven by a strong earnings beat, increased guidance, and strategic preparations for a significant HSA market expansion. The company's financial performance and positive analyst sentiment suggest continued growth and market leadership, making it a compelling investment opportunity.
Performance & Financial Health Analysis: Doximity vs HealthEquity
| Metric | DOCS | HQY |
|---|---|---|
| Market Information | ||
| Market Cap | $14.07B | $7.96B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 1,577,510 | 857,337 |
| 90 Day Avg. Volume | 1,326,787 | 1,120,722 |
| Last Close | $71.99 | $89.68 |
| 52 Week Range | $40.87 - $85.21 | $74.07 - $116.65 |
| % from 52W High | -15.51% | -23.12% |
| All-Time High | $107.79 (Sep 06, 2021) | $116.65 (Jun 05, 2025) |
| % from All-Time High | -33.21% | -23.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.09% |
| Quarterly Earnings Growth | 0.29% | 0.67% |
| Financial Health | ||
| Profit Margin (TTM) | 0.40% | 0.11% |
| Operating Margin (TTM) | 0.37% | 0.28% |
| Return on Equity (TTM) | 0.24% | 0.07% |
| Debt to Equity (MRQ) | 1.16 | 49.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.47 | $24.84 |
| Cash per Share (MRQ) | $4.49 | $3.53 |
| Operating Cash Flow (TTM) | $294.12M | $366.90M |
| Levered Free Cash Flow (TTM) | $231.29M | $288.23M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Doximity vs HealthEquity
| Metric | DOCS | HQY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 63.66 | 55.99 |
| Forward P/E | 63.13 | 24.58 |
| PEG Ratio | 2.33 | 0.82 |
| Price to Sales (TTM) | 23.63 | 6.27 |
| Price to Book (MRQ) | 13.73 | 3.65 |
| Market Capitalization | ||
| Market Capitalization | $14.07B | $7.96B |
| Enterprise Value | $13.24B | $8.92B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.46 | 7.03 |
| Enterprise to EBITDA | 54.29 | 20.70 |
| Risk & Other Metrics | ||
| Beta | 1.37 | 0.50 |
| Book Value per Share (MRQ) | $5.47 | $24.84 |
Financial Statements Comparison: Doximity vs HealthEquity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DOCS | HQY |
|---|---|---|
| Revenue/Sales | $145.91M | $330.84M |
| Cost of Goods Sold | $15.79M | $106.53M |
| Gross Profit | $130.12M | $224.31M |
| Research & Development | $26.80M | $61.44M |
| Operating Income (EBIT) | $54.52M | $84.35M |
| EBITDA | $57.31M | $125.83M |
| Pre-Tax Income | $64.15M | $70.95M |
| Income Tax | $10.83M | $17.04M |
| Net Income (Profit) | $53.32M | $53.92M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DOCS | HQY |
|---|---|---|
| Cash & Equivalents | $209.61M | $287.89M |
| Total Current Assets | $1.09B | $472.80M |
| Total Current Liabilities | $156.26M | $116.34M |
| Long-Term Debt | $10.19M | $1.10B |
| Total Shareholders Equity | $1.08B | $2.12B |
| Retained Earnings | $186.89M | $218.35M |
| Property, Plant & Equipment | $8.89M | $41.45M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DOCS | HQY |
|---|---|---|
| Operating Cash Flow | $119.90M | $64.74M |
| Capital Expenditures | $0 | $-86,000 |
| Free Cash Flow | $96.98M | $48.60M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-26.79M | $-59.07M |
Short Interest & Institutional Ownership Analysis
| Metric | DOCS | HQY |
|---|---|---|
| Shares Short | 4.82M | 4.41M |
| Short Ratio | 3.93 | 3.57 |
| Short % of Float | 0.04% | 0.06% |
| Average Daily Volume (10 Day) | 1,577,510 | 857,337 |
| Average Daily Volume (90 Day) | 1,326,787 | 1,120,722 |
| Shares Outstanding | 188.88M | 86.54M |
| Float Shares | 133.22M | 84.54M |
| % Held by Insiders | 0.02% | 0.02% |
| % Held by Institutions | 0.91% | 1.08% |
Dividend Analysis & Yield Comparison: Doximity vs HealthEquity
| Metric | DOCS | HQY |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |